Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.57 -0.04 (-6.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Receivables (2026)

Updated

Tenaya Therapeutics' Receivables came in at $371,000 for Q2 2026, down 96.5% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Receivables (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 19.05 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 13.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.68 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 5.06 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.13 Bn
10 Tenaya Therapeutics 134.54 Mn 134.54 Mn - 371,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 371,000.00
Mar 31, 2026 10.63 Mn
API Access

Tenaya Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=TNYA&period=max&api_key=YOUR_API_KEY